Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11320%2F13%3A10144237" target="_blank" >RIV/00216208:11320/13:10144237 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/13:10144237 RIV/00064165:_____/13:10144237
Result on the web
<a href="http://www.ecco-jccjournal.org/article/S1873-9946(12)00456-4/abstract" target="_blank" >http://www.ecco-jccjournal.org/article/S1873-9946(12)00456-4/abstract</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.crohns.2012.10.019" target="_blank" >10.1016/j.crohns.2012.10.019</a>
Alternative languages
Result language
angličtina
Original language name
Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
Original language description
Background and aims: Over 10% of Crohn's disease (CD) patients annually lose response to infliximab. Infliximab trough levels (TL), concomitant immunosuppressants and endoscopic healing were proposed as predictors of favourable infliximab outcome. We assessed infliximab TL measured after induction therapy as predictors of sustained clinical response. Furthermore, we tried to identify other predictors of long-term benefit of infliximab therapy. Methods: We included CD patients treated with infliximab between October 2007 and March 2010 who responded to 3-dose induction followed by maintenance therapy and in whom blood samples taken at treatment week 14 or 22 were available in blood bank. Sustained response to infliximab was defined as absence of treatment failure due to loss of response or drug intolerance. Results: Eighty four patients were included. Sustained response to infliximab was observed in 47 (56%) patients during a median follow-up of 25 months (14-37). lnfliximab TL>3 mu g/m
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
BB - Applied statistics, operational research
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Crohn's and Colitis
ISSN
1873-9946
e-ISSN
—
Volume of the periodical
7
Issue of the periodical within the volume
9
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
8
Pages from-to
736-743
UT code for WoS article
000323995900007
EID of the result in the Scopus database
—